Does TACROLIMUS Cause Upper respiratory tract infection? 260 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 260 reports of Upper respiratory tract infection have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.3% of all adverse event reports for TACROLIMUS.
260
Reports of Upper respiratory tract infection with TACROLIMUS
0.3%
of all TACROLIMUS reports
38
Deaths
160
Hospitalizations
How Dangerous Is Upper respiratory tract infection From TACROLIMUS?
Of the 260 reports, 38 (14.6%) resulted in death, 160 (61.5%) required hospitalization, and 69 (26.5%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 260 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which TACROLIMUS Alternatives Have Lower Upper respiratory tract infection Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB